Healionics Corporation Email Format

Medical Equipment ManufacturingWashington, United States11-50 Employees

Healionics Corporation develops medical devices based on synthetic biomaterials to improve vascular access for dialysis. Its lead product, the STARgraft vascular graft, aims to provide safer, more reliable bloodstream access by reducing occlusion and infection with current devices. The company also advances a STAR biomaterial platform designed to mitigate scarring and infection in implantable devices, and it has 36 patents issued or pending, with human studies ongoing for STARgraft.

Based in Seattle, Washington, the company operates in the medical equipment manufacturing sector, focusing on devices for dialysis patients and the clinicians who care for them. In 2024, STARgraft received FDA Breakthrough Device designation, reflecting regulatory recognition of its potential to improve dialysis access outcomes.

Sign up for free to view info

Company overview Employee directory